Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience).
Background. The aim of the study was to investigate the changes in plasma lipids and lipoproteins and the cardiovascular events after selective LDL apheresis. Methods and Results. Two pediatric patients with familial hypercholesterolemia aged 11 and 13 years and 19 dyslipidemic adults aged 41 ± 14 years underwent direct adsorption of lipoproteins (DALI) sessions. The mean follow-up period was 47 ± 23 months. The total cholesterol (TC) values before and after treatment were 8.2 ± 2.2 and 3.1 ± 1.6 mmol/l (318 ± 86 and 122 ± 62 mg/dL), respectively. The interval mean of TC was 6.9 ± 1.9 mmol/l (268 ± 75 mg/dL). The LDL cholesterol concentrations before and after treatment were 6.6 ± 2.1 and 1.7 ± 1.1 mmol/l, (256 ± 82 mg/dL and 65 ± 41 mg/dL), respectively. The percentage of acute LDL cholesterol reduction was 75 ± 11%. Cardiovascular events were observed in seven patients. The average annual event rate was 5.51%. Conclusion. LDL apheresis is a very important therapeutic tool in managing patients at high risk for premature CAD or with aggressive CAD, despite adequate medical treatment.
1st Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
Genovefa
G
Kolovou
Georgios
G
Hatzigeorgiou
Constantinos
C
Mihas
Nikos
N
Gontoras
Panagiotis
P
Litras
Dimitris
D
Devekousos
Panagiota
P
Kontodima
Constantina
C
Sorontila
Helen
H
Bilianou
Sophie
S
Mavrogeni